JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB273162

Human IL-17AF ELISA kit

Be the first to review this product! Submit a review

|

(0 Publication)

Human IL-17AF ELISA kit is a Sandwich (quantitative) ELISA for the measurement of Human IL-17AF in Human in Biofluids, Cell Culture Media samples.

View Alternative Names

CTLA8, IL17, IL17A, Interleukin-17A, IL-17, IL-17A, Cytotoxic T-lymphocyte-associated antigen 8, CTLA-8

1 Images
ELISA - Human IL-17AF ELISA kit (AB273162)
  • ELISA

Supplier Data

ELISA - Human IL-17AF ELISA kit (AB273162)

Typical standard curve – data provided for demonstration purposes only. A new standard curve must be generated for each assay performed.

Example of Human IL-17AF ELISA kit standard curve.

Key facts

Detection method

Colorimetric

Sample types

Plasma, Cell culture supernatant, Serum

Reacts with

Human

Assay type

Sandwich (quantitative)

Sensitivity

= 6.6 pg/mL

Range

15.6 - 500 pg/mL

Assay time

3h 45m

Assay Platform

Microplate (12 x 8 well strips)

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "sELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Human IL-17AF ELISA kit (ab273162) is for the in vitro qualitative and quantitative determination of IL-17AF in supernatants, buffered solutions or serum and plasma samples and other body fluids. This assay will recognise both natural and recombinant human IL-17AF.

A highly specific capture antibody has been coated to the wells of the microtitre strip plate provided during manufacture. Binding of IL-17AF in samples and known standards to the capture antibodies is completed and then any excess unbound analyte is removed.

During the next incubation period the binding of the biotinylated secondary antibody to the analyte occurs. Any excess unbound secondary antibody is then removed.

The HRP conjugate solution is then added to every well including the zero wells, following incubation excess conjugate is removed by careful washing.

A chromogen substrate is added to the wells resulting in the progressive development of a blue coloured complex with the conjugate. The colour development is then stopped by the addition of acid turning the resultant final product yellow. The intensity of the produced coloured complex is directly proportional to the concentration of IL-17AF present in the samples and standards.

The absorbance of the colour complex is then measured and the generated OD values for each standard are plotted against expected concentration forming a standard curve. This standard curve can then be used to accurately determine the concentration of IL-17AF in any sample tested.

Precision

[ { "reproducibilityType": "Inter", "sample": "Sample 1", "replicates": 9, "mean": "230.1 pg/mL", "standardDeviation": "9.7", "coefficientOfVariability": "4.2" }, { "reproducibilityType": "Inter", "sample": "Sample 2", "replicates": 9, "mean": "313.2 pg/mL", "standardDeviation": "20.1", "coefficientOfVariability": "6.4" }, { "reproducibilityType": "Inter", "sample": "Sample 3", "replicates": 9, "mean": "435.3 pg/mL", "standardDeviation": "31.3", "coefficientOfVariability": "7.2" }, { "reproducibilityType": "Intra", "sample": "Sample 1", "replicates": 9, "mean": "230.3 pg/mL", "standardDeviation": "8.1", "coefficientOfVariability": "3.5" }, { "reproducibilityType": "Intra", "sample": "Sample 2", "replicates": 9, "mean": "313.4 pg/mL", "standardDeviation": "19.2", "coefficientOfVariability": "6.1" }, { "reproducibilityType": "Intra", "sample": "Sample 3", "replicates": 9, "mean": "435.5 pg/mL", "standardDeviation": "32.4", "coefficientOfVariability": "7.5" } ]

Recovery

[ { "sample": "Serum", "range": "77 - 117 %", "average": "= 102" } ]

What's included?

{ "values": { "1x96Tests": { "sellingSize": "1 x 96 Tests", "publicAssetCode":"ab273162-1x96Tests", "assetComponentDetails": [ { "size":"1 x 23 mL", "name":"HRP Diluent", "number":"AB273162-CMP03", "productcode":"" }, { "size":"2 x 1 Vial", "name":"IL-17AF Standard", "number":"AB273162-CMP11", "productcode":"" }, { "size":"1 x 400 µL", "name":"Biotinylated Antibody IL-17AF", "number":"AB273162-CMP02", "productcode":"" }, { "size":"2 x 5 µL", "name":"Streptavidin-HRP", "number":"AB273162-CMP05", "productcode":"" }, { "size":"1 x 11 mL", "name":"Stop Reagent", "number":"AB273162-CMP08", "productcode":"" }, { "size":"1 x 10 mL", "name":"Wash Buffer", "number":"AB273162-CMP06", "productcode":"" }, { "size":"1 x 1 Unit", "name":"IL-17AF Coated Microwell strips", "number":"AB273162-CMP10", "productcode":"" }, { "size":"1 x 25 mL", "name":"Standard diluent Buffer", "number":"AB273162-CMP07", "productcode":"" }, { "size":"2 x 1 Unit", "name":"Plastic Plate Cover", "number":"AB273162-CMP09", "productcode":"" }, { "size":"1 x 11 mL", "name":"TMB Substrate", "number":"AB273162-CMP04", "productcode":"" }, { "size":"1 x 7 mL", "name":"Biotinylated Antibody diluent", "number":"AB273162-CMP01", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
+4°C

Product protocols

Target data

Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity (PubMed : 24120361). Signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrobial peptides and matrix metalloproteinases, with potential strong immune inflammation (PubMed : 17911633, PubMed : 18684971, PubMed : 19825828, PubMed : 21350122, PubMed : 24120361, PubMed : 8676080). Plays an important role in connecting T cell-mediated adaptive immunity and acute inflammatory response to destroy extracellular bacteria and fungi. As a signature effector cytokine of T-helper 17 cells (Th17), primarily induces neutrophil activation and recruitment at infection and inflammatory sites (By similarity). In airway epithelium, mediates neutrophil chemotaxis via induction of CXCL1 and CXCL5 chemokines (By similarity). In secondary lymphoid organs, contributes to germinal center formation by regulating the chemotactic response of B cells to CXCL12 and CXCL13, enhancing retention of B cells within the germinal centers, B cell somatic hypermutation rate and selection toward plasma cells (By similarity). Effector cytokine of a subset of gamma-delta T cells that functions as part of an inflammatory circuit downstream IL1B, TLR2 and IL23A-IL12B to promote neutrophil recruitment for efficient bacterial clearance (By similarity). Effector cytokine of innate immune cells including invariant natural killer cell (iNKT) and group 3 innate lymphoid cells that mediate initial neutrophilic inflammation (By similarity). Involved in the maintenance of the integrity of epithelial barriers during homeostasis and pathogen infection (PubMed : 21350122). Upon acute injury, has a direct role in epithelial barrier formation by regulating OCLN localization and tight junction biogenesis (By similarity). As part of the mucosal immune response induced by commensal bacteria, enhances host's ability to resist pathogenic bacterial and fungal infections by promoting neutrophil recruitment and antimicrobial peptides release (By similarity). In synergy with IL17F, mediates the production of antimicrobial beta-defensins DEFB1, DEFB103A, and DEFB104A by mucosal epithelial cells, limiting the entry of microbes through the epithelial barriers (By similarity). Involved in antiviral host defense through various mechanisms (By similarity). Enhances immunity against West Nile virus by promoting T cell cytotoxicity (By similarity). May play a beneficial role in influenza A virus (H5N1) infection by enhancing B cell recruitment and immune response in the lung (By similarity). Contributes to influenza A virus (H1N1) clearance by driving the differentiation of B-1a B cells, providing for production of virus-specific IgM antibodies at first line of host defense (By similarity).
See full target information IL17A
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com